FI45551C - Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate. - Google Patents

Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.

Info

Publication number
FI45551C
FI45551C FI268068A FI268068A FI45551C FI 45551 C FI45551 C FI 45551C FI 268068 A FI268068 A FI 268068A FI 268068 A FI268068 A FI 268068A FI 45551 C FI45551 C FI 45551C
Authority
FI
Finland
Prior art keywords
monanthate
dehydroepiandro
osterone
preparation
therapeutically useful
Prior art date
Application number
FI268068A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI45551B (en
Inventor
Ufer Joachim
Engelfried Otto
Wiechert Rudolf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of FI45551B publication Critical patent/FI45551B/fi
Publication of FI45551C publication Critical patent/FI45551C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI268068A 1967-10-04 1968-09-23 Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate. FI45551C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC041382 1967-10-04

Publications (2)

Publication Number Publication Date
FI45551B FI45551B (en) 1972-04-04
FI45551C true FI45551C (en) 1972-07-10

Family

ID=7436199

Family Applications (1)

Application Number Title Priority Date Filing Date
FI268068A FI45551C (en) 1967-10-04 1968-09-23 Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.

Country Status (12)

Country Link
AT (1) AT297946B (en)
BE (1) BE721825A (en)
BR (1) BR6802861D0 (en)
CS (1) CS150596B2 (en)
DK (1) DK122125B (en)
FI (1) FI45551C (en)
FR (2) FR1584879A (en)
GB (1) GB1246639A (en)
IE (1) IE32405B1 (en)
NL (1) NL160835C (en)
SE (1) SE352347B (en)
YU (1) YU33834B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63267722A (en) * 1987-04-27 1988-11-04 Daiichi Yakuhin Sangyo Kk Anti-obesity agent
US4835147A (en) * 1987-05-06 1989-05-30 City Of Hope Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
DE69433994T2 (en) * 1993-01-19 2005-09-22 Endorecherche Inc., Ste-Foy THERAPEUTIC USES AND ADMINISTRATION SYSTEMS OF DEHYDROEPIANDROSTERONE
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CN110585124A (en) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 An oily injection containing estriol or its derivatives

Also Published As

Publication number Publication date
DE1643046B2 (en) 1975-11-27
YU224068A (en) 1977-12-31
BE721825A (en) 1969-04-04
DE1643046A1 (en) 1971-06-16
YU33834B (en) 1978-06-30
NL160835C (en) 1979-12-17
AT297946B (en) 1972-03-15
NL160835B (en) 1979-07-16
DK122125B (en) 1972-01-24
CS150596B2 (en) 1973-09-04
BR6802861D0 (en) 1973-03-15
FR8191M (en) 1970-09-07
FR1584879A (en) 1970-01-02
FI45551B (en) 1972-04-04
GB1246639A (en) 1971-09-15
NL6814196A (en) 1969-04-09
IE32405L (en) 1969-04-04
SE352347B (en) 1972-12-27
IE32405B1 (en) 1973-07-25

Similar Documents

Publication Publication Date Title
FI49035C (en) Process for the preparation of therapeutically useful 2-bromo-alpha-gocryptine.
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
FI47364C (en) Process for the preparation of therapeutically valuable 3-indolyl-aliphatic-acid compounds.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
FI48727C (en) Process for the preparation of acetylguanidines.
FI48746C (en) Process for the preparation of tetrapolymer latex.
FI52335C (en) Process for the preparation of therapeutically active ethylamine derivatives.
FI46373C (en) A process for the preparation of new therapeutically useful derivatives of phenylaminopropane.
FI52857C (en) Process for the preparation of therapeutically active amidoximes.
FI49971C (en) Process for the preparation of microbicide-2-nitrofurfurylidenindanone derivatives.
FI50334C (en) Process for the preparation of 1-hydroxy-2-pyridones.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI45041C (en) Process for the preparation of therapeutically useful pyrrole derivatives.
FI47489C (en) Process for the preparation of anti-inflammatory 5- (1-aroyl-3-indolyl-methyl) -tetrazoles.
FI50975C (en) Process for the preparation of pyrazinamide derivatives.
FI50970C (en) Process for the preparation of antifibrinolytic aminomethyl-bisyclocarboxylic acids.
FI51812C (en) Process for the preparation of acyloxymethyl esters of alpha-aminobenzylpenicillin.
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI48724C (en) Process for the preparation of N-carbamoyloxyphenyl carbamates.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI48088C (en) Process for the preparation of 5-phenyl-1H-1,4-benzodiazepine derivatives
FI46727C (en) Process for the preparation of pyridazole derivatives.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI47358C (en) Process for the preparation of therapeutically useful 4'-demethyl-epi podophyllotoxin-beta-D-glucoside.